Literature DB >> 903989

Cytologic evaluation of breast fluid in the detection of breast disease.

O W Sartorius, H S Smith, P Morris, D Benedict, L Friesen.   

Abstract

The availability and cell content of aspirated breast fluid from 1,706 women were evaluated to determine the usefulness of breast fluid cytology as an indicator of breast disease. A newly developed aspirator was used to obtain cells adequate for diagnosis from approximately 50% of the women tested. Fluids were most readily available from women between the ages of 30 and 50 years. Although abnormal cytologies were observed in all age groups, the relative proportion of abnormal specimens as well as the degree of abnormality increased as a function of age. More women over 40 years of age with a high risk of breast cancer had cells classified in the more abnormal categories than did women in the normal risk group. To localize otherwise occult lesions, contrast ductography was performed on all women with very abnormal ductal cells. Women with atypical hyperplastic cytologies most commonly had benign and premalignant breast disease at subsequent biopsy. Of 27 women with fluids classified as suspected carcinomas 18 (66%) had small carcinomas. These observations strongly suggested that the presence of atypical cells in aspirated breast fluids has important clinical application for early detection of breast cancer. One limitation of cytology was that the technique rarely detected carcinomas greater than 1 cm.

Entities:  

Mesh:

Year:  1977        PMID: 903989     DOI: 10.1093/jnci/59.4.1073

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  30 in total

Review 1.  Novel agents for chemoprevention, screening methods, and sampling issues.

Authors:  Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

2.  Cerumen phenotype and proliferative epithelium in breast fluids of U.S.-born vs. immigrant Asian women: a possible genetic-environmental interaction.

Authors:  N L Petrakis; E B King; M Lee; R Miike
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

3.  Potential for cytologic breast fluid analysis in breast disease.

Authors:  S H Dairkee; A J Hackett
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 4.  Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid.

Authors:  N L Petrakis
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 5.  Familial breast cancer.

Authors:  D G Evans; I S Fentiman; K McPherson; D Asbury; B A Ponder; A Howell
Journal:  BMJ       Date:  1994-01-15

6.  Growth of normal human mammary cells in culture.

Authors:  M Stampfer; R C Hallowes; A J Hackett
Journal:  In Vitro       Date:  1980-05

7.  Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.

Authors:  Angela J Fought; Claire McGathey; Denise M Scholtens; Richard E Heinz; Rick Lowe; Yvonne B Feeney; Oukseub Lee; Thomas E Kmiecik; Judith A Wolfman; Charles V Clevenger; Peter H Gann; Susan Gapstur; Robert T Chatterton; Seema A Khan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-18       Impact factor: 4.254

8.  Status of Intraductal Therapy for Ductal Carcinoma in Situ.

Authors:  Meghan Flanagan; Susan Love; E Shelley Hwang
Journal:  Curr Breast Cancer Rep       Date:  2010-05-06

Review 9.  Early detection of breast cancer: new biomarker tests on the horizon?

Authors:  Aparna C Jotwani; Julie R Gralow
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

10.  The biochemistry of breast cyst fluids and duct secretions.

Authors:  O W Sartorius
Journal:  Breast Cancer Res Treat       Date:  1995-09       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.